DNDN OT-rkcrules, Thanks for the acknowledgement...I've had a little more free time in the past month, and there has been some encouraging information for the company (which did nothing for the stock price, of course). IMO it has one of the two or three highest potential upsides of any developmental biotechs with market caps under $300 million.
Market Data 
Markets 
AI
